Friday, May 1, 2026

Biggest Password Leak Ever Hits Apple, Gmail, Facebook & More

Over 1.6 billion login credentials compromised in history's largest data breach, affecting major platforms and urging stronger cybersecurity measures.

5 Key Takeaways from Prime Minister Kim’s First Official U.S. Trip: Strengthening Korea-U.S. Relations

South Korean PM Kim Min-seok embarks on his first overseas trip to the U.S. to strengthen bilateral relations and discuss key issues.

How Cortiss’s “REDRED” Captured the Top Spots in 24 Countries: Insights and Trends

Cortis rises in the music scene with "REDRED," topping charts globally and achieving impressive views and rankings in various regions.

Tag: pharmacokinetics

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

Top News

- Our Sponsors Ad -

Follow us